Visual Place Recognition From Eye Reflection

The cornea in the human eye reflects incoming environmental light, which means we can obtain information about the surrounding environment from the corneal reflection in facial images. In recent years, as the quality of consumer cameras increases, this has caused privacy concerns in terms of identifying the people around the subject or where the photo is taken. This paper investigates the security risk of eye corneal reflection images: specifically, visual place recognition from eye reflection images. First, we constructed two datasets containing pairs of scene and corneal reflection images. The first dataset is taken in a virtual environment. We showed pre-captured scene images in a 180-degree surrounding display system and took corneal reflections from subjects. The second dataset is taken in an outdoor environment. We developed several visual place recognition algorithms, including CNN-based image descriptors featuring a naive Siamese network and AFD-Net combined with entire image feature representations including VLAD and NetVLAD, and compared the results. We found that AFD-Net+VLAD performed the best and was able to accurately determine the scene in 73.08% of the top-five candidate scenes. These results demonstrate the potential to estimate the location at which a facial picture was taken, which simultaneously leads to a) positive applications such as the localization of a robot while conversing with persons and b) negative scenarios including the security risk of uploading facial images to the public

Histological Observation of Regions around Bone Tunnels after Compression of the Bone Tunnel Wall in Ligament Reconstruction

The objectives of this study were to investigate the time-course of influence of compression of bone tunnel wall in ligament reconstruction on tissue around the bone tunnel and to histologically examine the mechanism of preventing the complication of bone tunnel dilation, using rabbit tibia. A model in which the femoral origin of the extensor digitorum longus tendon was cut and inserted into a bone tunnel made proximal to the tibia was prepared in the bilateral hind legs of 20 Japanese white rabbits. In each animal, a tunnel was made using a drill only in the right leg, while an undersized bone tunnel was made by drilling and then dilated by compression using a dilator to the same tunnel size as that in the right leg. Animals were sacrificed at 0, 2, 4, 8 and 12 weeks after surgery (4 animals at each time point). Observation of bone tunnels by X-ray radiography showed osteosclerosis in the 2- and 4-week dilation groups. Osteosclerosis appeared as white lines around the bone tunnel on X-ray radiography. This suggests that dilation promotes callus formation in the bone tunnel wall and prevents the complication of bone tunnel enlargement after ligament reconstruction

Salvage Haploidentical Transplantation Using Low-dose ATG for Early Disease Relapse after First Allogeneic Transplantation: A Retrospective Single-center Review

Second allogeneic stem cell transplantation (allo-SCT) is a potentially curative therapy for patients who relapse after first allo-SCT. Human leukocyte antigen (HLA)-haploidentical related donors provide the broad opportunity to conduct second SCT at the appropriate time, but the efficacy of second SCT from haploidentical donors after relapse has not been established. We retrospectively analyzed the records of 33 patients who underwent second SCT. Twenty patients underwent haplo-SCT with low-dose antithymocyte globulin (ATG), and the other 13 patients underwent conventional- SCTs, including HLA-matched related peripheral blood, unrelated bone marrow or cord blood. Three years after the second SCT, the overall survival (OS) and progression-free survival (PFS) of all patients were 32.5% and 23.9%. Multivariate analyses indicated that non-complete response at second SCT, less than 1-year interval to relapse after first- SCT, and total score ≥ 3 on the hematopoietic cell transplantation-specific comorbidity index were significantly associated with a lower PFS rate. The haplo- and conventional- SCT groups showed equivalent results regarding OS, PFS, cumulative incidences of relapse, non-relapse mortality and graft-versus-host disease. The neutropenic period after transplantation was significantly shorter in haplo- SCT than conventional- SCT (10.5 days vs. 16 days, p=0.001). Our analysis revealed that haplo-SCT could be an alternative therapeutic option for relapsed patients after first SCT